exRNAdisease

Entry Detail

---



General Information

Database ID: exR0275429 RNA Name: hsa-miR-205-5p RNA Type: miRNA Chromosome: chr1 Starnd: + Coordinate: Start Site(bp): 209432166 End Site(bp): 209432187 External Links: hsa-miR-205-5p

Disease Information

Disease Name: Advanced Adenoma Disease Category: Cancers MeSH ID: D000236 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas

Expression Detail

GEO ID: GSE25609 Description: Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening Experimental Design: Cancer vs Control Case Disease Type: Advanced Adenoma Case Disease SubType: NA Case Sample: Advanced Adenoma Post surgery Control Sample: Control Number of Case: 20 Number of Control: 20 Number of Samples: 40

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand DOCK6 chr19 11199295 11262524 - MKRN2 chr3 12557087 12583713 + NUP93 chr16 56730118 56850286 + EP300 chr22 41092592 41180077 + CDC42 chr1 22025511 22101360 + LSM1 chr8 38163335 38176730 - TSPYL4 chr6 116249964 116254075 - HINT1 chr5 131159027 131171735 - YTHDF2 chr1 28736621 28769775 + PPP3CC chr8 22440819 22541142 + SLTM chr15 58879050 58933679 - RUNX1T1 chr8 91954967 92103286 - CALM3 chr19 46601074 46610782 + PRKCSH chr19 11435288 11450968 + SFPQ chr1 35176378 35193145 - PLXNA1 chr3 126988594 127037392 + KAZN chr1 13892792 15118043 + OGDH chr7 44606572 44709066 + ZCCHC8 chr12 122471599 122501073 - SLC25A3 chr12 98593591 98606379 + AFF4 chr5 132875395 132963634 - CAPZA2 chr7 116811070 116922049 + SLC3A2 chr11 62856102 62888875 + ACSL1 chr4 184755595 184826818 - XRCC6 chr22 41621119 41664048 + NDUFAF1 chr15 41387353 41402519 - SOSTDC1 chr7 16461481 16530580 - E2F1 chr20 33675477 33686385 - CCZ1B chr7 6794134 6826770 - GNPDA2 chr4 44682200 44726588 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001434 chr4 106345352 106377902 - hsa_circ_0001731 chr7 100731990 100738448 + hsa_circ_0000733 chr17 1561546 1562030 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC009133.5 chr16 29808679 29812227 + GAS5 chr1 173858559 173868882 - MALAT1 chr11 65497688 65506516 + MCM3AP-AS1 chr21 46229196 46259390 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + SNHG5 chr6 85650491 85678932 - AL356133.1 chr9 26801733 26805862 + Display:

Experiment Detail

GEO ID: GSE25609 Sample Source: Blood Source Fraction: Plasma Platform: GPL8179 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 826 Sample treatment protocol: Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components. RNA Extract protocol: NA RNA library preparation protocol: Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).

Reference

PMID: 23267864 Title: Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Author: Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M Journal: Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3. Description: We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.